Marlene Martin, MD

Associate Professor and Director of Addiction Care Team

Marlene Martin, MD, is an Associate Professor of Clinical Medicine at UCSF and a hospitalist at San Francisco General Hospital (SFGH). Drawn to medicine to address health inequities and social injustices, her interests lie in systems improvement and innovation with a focus on addiction, community partnerships, Latine health, and care transitions. Marlene's bilingual and bicultural Mexican immigrant background drew her to work in the safety net. She was born and raised in Los Angeles and is a first-generation college graduate. Marlene attended college and medical school at Stanford, was a NIH Fogarty Scholar in Peru, and completed internal medicine residency at UCSF.

She worked at Santa Clara Valley Medical Center for two years where she led inpatient addiction work before joining the UCSF at SFGH hospitalist division. At SFGH she is a former member of the Health Equity Council and co-chair of the Care Transitions Task Force. She was a coach for students between 2019-2023 in the UCSF San Joaquin Valley Program in Medical Education (PRIME) and is dedicated to diversifying the healthcare workforce.

Through the UCSF Latinx Center of Excellence (LCOE), Marlene led the implementation of a Latine COVID-19 Enhanced Case Investigation and Contact Tracing in partnership with Latine promotores between 2020-2021 and served as a technical assistant in the community health worker academy from 2021-2022. Through her role as the Director of Addiction Initiatives for the UCSF LCOE she aims to improve the health of Latine individuals in San Francisco with unhealthy substance use and develop novel care models that can be implemented in other settings. With California Health Care Foundation funding, she is co-leading the Program for Education in Drugs and Alcohol for Latine (PEDAL), a Spanish-language curriculum. In partnership with UCSF, the National Harm Reduction Coalition, and 4 Latine CBOs in San Francisco, she co-developed, implemented, and evaluated PEDAL which trained 20 promotores (community health workers) to communicate about substance use, recognize unhealthy use, and link community members to services to both prevent and treat addiction.

Marlene is board certified in internal medicine and addiction medicine and founded and directs the nationally recognized Addiction Care Team (ACT) since 2019. ACT is an interprofessional consult service that provides compassionate care focused on compassionate evidence-based treatment, harm reduction, and linkage to care for patients with substance use disorders. Through this, she has worked with hospital and community partners to address stigma through campus substance use policies, harm reduction efforts, clinician and nursing education (ACT Nurse Liaison Program), and an anti-stigma campaign.
Education
2018 - Diversity, Equity, and Inclusion Champion Training, UCSF
Residency, 2015 - Internal Medicine, UCSF
MD, 2012 - School of Medicine, Stanford University
BA, Honors, 2006 - Human Biology, Stanford University
Honors and Awards
  • Council of Master Clinicians, UCSF, 2024
  • Clinical Innovator Award, UCSF Department of Medicine, 2022
  • COVID-19 Heroes Award, California Senate District 11, 2021
  • Social Justice Award, UCSF Division of Hospital Medicine, 2021
  • Fellow, California Health Care Foundation, 2020-2022
  • Top 40 under 40 Leaders in Minority Health, National Minority Quality Forum, 2020
  • John A. Watson Scholar, University of California, San Francisco, 2019-2022
  • Young Physician of the Year, National Hispanic Medical Association, 2019
Websites
Publications
  1. Hidden
    The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

    Garg M, Oliva J, Lu A, Martin M, Hooper S. Hospital-Based Medical-Legal Partnerships for Complex Care Patients: Intersectionality and Ethics Considerations. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 2024. PMID: 38477278


  2. Hidden
    JAMA network open
  3. Hidden
    JAMA network open

    Fraimow-Wong L, Martín M, Thomas L, Giuliano R, Nguyen OK, Knight K, Suen LW. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction. JAMA network open 2024. PMID: 38386317


  4. Hidden
    Journal of addiction medicine
  5. Hidden
    Journal of addiction medicine

    Carson M, Fernandez A, Martin M. A Review of Community Health Worker Interventions for Latinx/o/a Individuals With Unhealthy Alcohol Use. Journal of addiction medicine 2023. PMID: 37585265


  6. Hidden
    Journal of hospital medicine

    Haber LA, Nguyen OK, Taub J, Martin M. Policy in clinical practice: Elimination of the buprenorphine "X-waiver". Journal of hospital medicine 2023. PMID: 37545111


  7. Hidden
    Journal of hospital medicine

    Martin M, Englander H, Calcaterra SL. Things We Do for No Reason™: Avoiding methadone for opioid withdrawal. Journal of hospital medicine 2023. PMID: 37244869


  8. Hidden
    Substance use & misuse

    Tierney HR, Takimoto SW, Azari S, Steiger S, Martin M. Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting. Substance use & misuse 2023. PMID: 37194561


  9. Hidden
    JAMA network open

    Calcaterra SL, Martin M, Englander H. Identifying Barriers to OUD Treatment Linkage From the Emergency Department to the Community. JAMA network open 2023. PMID: 37163270


  10. Hidden
    Journal of clinical pharmacy and therapeutics

    Ciraldo K, Seraydarian M, Gasper J, DeFries T, Martin M. Extended-release naltrexone for people with alcohol use disorder on therapeutic anticoagulation: A case series. Journal of clinical pharmacy and therapeutics 2022. PMID: 36511083


  11. Hidden
    Journal of addiction medicine

    Leyde S, Abbs E, Suen LW, Martin M, Mitchell A, Davis J, Azari S. A Mixed-methods Evaluation of an Addiction/Cardiology Pilot Clinic With Contingency Management for Patients With Stimulant-associated Cardiomyopathy. Journal of addiction medicine 2022. PMID: 37267175


  12. Hidden
    Journal of addiction medicine

    Martin M, Snyder HR, Otway G, Holpit L, Day LW, Seidman D. In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care. Journal of addiction medicine 2022. PMID: 35914181


  13. Hidden
    Journal of hospital medicine

    Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. Journal of hospital medicine 2022. PMID: 35880813


  14. Hidden
    Journal of hospital medicine

    Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. Journal of hospital medicine 2022. PMID: 35880821


  15. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    Perera R, Stephan L, Appa A, Giuliano R, Hoffman R, Lum P, Martin M. Meeting people where they are: implementing hospital-based substance use harm reduction. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2022. PMID: 35139877


  16. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    DeFries T, Kelley J, Martin M, Kimball SL. Immigration status matters: the intersectional risk of immigration vulnerability and substance use disorder. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2022. PMID: 35102631


  17. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    Garcia ME, Coffman J, Jordan A, Martin M. Lack of Racial and Ethnic Diversity Among Addiction Physicians. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2022. PMID: 35102480


  18. Hidden
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin PO, Jain V. Comparative one-year outcomes of invasive Staphylococcus aureus infections among persons with and without drug use: an observational cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021. PMID: 33904900


  19. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    Martin M, Clement J, Defries T, Makam AN, Nguyen OK. Prevalence and Characteristics of Hospitalizations with Unhealthy Alcohol Use in a Safety-Net Hospital from 2016 to 2018. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2022. PMID: 35060005


  20. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    Martin M. Beyond a Purple Journal: Improving Hospital-Based Addiction Care. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2021. PMID: 34910620


  21. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    DeFries T, Leyde S, Haber LA, Martin M. Things We Do for No Reason™: Prescribing Thiamine, Folate and Multivitamins on Discharge for Patients With Alcohol Use Disorder. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2021. PMID: 34730500


  22. Hidden
    "Are Telehealth Visits Feasible for Vulnerable Patients?"

    Bottner R, Bratberg J, Martin M, Weimer MB, Jordan A, Tierney M. Don't "Waive" Goodbye to Education for Opioid Use Disorder. "Are Telehealth Visits Feasible for Vulnerable Patients?" 2021. PMID: 34901777


  23. Hidden
    Journal of general internal medicine

    Suen LW, Makam AN, Snyder HR, Repplinger D, Kushel MB, Martin M, Nguyen OK. National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018. Journal of general internal medicine 2021. PMID: 34518978


  24. Hidden
    The American journal of medicine

    Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin P, Jain V. Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive S. aureus Infections: Opportunities for Improvement. The American journal of medicine 2021. PMID: 34508704


  25. Hidden
    JAMA network open

    Cervantes L, Martin M, Frank MG, Farfan JF, Kearns M, Rubio LA, Tong A, Matus Gonzalez A, Camacho C, Collings A, Mundo W, Powe NR, Fernandez A. Experiences of Latinx Individuals Hospitalized for COVID-19: A Qualitative Study. JAMA network open 2021. PMID: 33704475


  26. Hidden
    Substance abuse

    Hagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Substance abuse 2021. PMID: 33465013


  27. Hidden
    BMJ open quality

    Martin M, Snyder HR, Coffa D, Steiger S, Clement JP, Ranji SR, Azari S, Nguyen OK, Lum PJ. Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system. BMJ open quality 2021. PMID: 33500326


  28. Hidden
    Journal of addiction medicine

    Marks LR, Liang SY, Durkin MJ, Martin M, White KD, See I. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections. Journal of addiction medicine 2020. PMID: 32187111


  29. Hidden
    Journal of hospital medicine

    Englander H, Salisbury-Afshar E, Gregg J, Martin M, Snyder H, Weinstein Z, King C. Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID-19. Journal of hospital medicine 2020. PMID: 32966196


  30. Hidden
    Journal of hospital medicine

    Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder. Journal of hospital medicine 2019. PMID: 31634100


  31. Hidden
    Journal of hospital medicine

    Haber LA, DeFries T, Martin M. Things We Do for No Reason™: Discontinuing Buprenorphine When Treating Acute Pain. Journal of hospital medicine 2019. PMID: 31433765


  32. Hidden
    JAMA internal medicine

    Martin M. Providing Comprehensive Health Care for Undocumented People in the United States. JAMA internal medicine 2019. PMID: 30575858


  33. Hidden
    The New England journal of medicine

    Martin M. Crossing Borders. The New England journal of medicine 2018. PMID: 30044723


  34. Hidden
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

    Martin M, Sauer T, Alarcon JA, Vinoles J, Walter EC, Ton TG, Zunt J. Prevalence and impact of asthma among school-aged students in Lima, Peru. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2017. PMID: 29037303


  35. Hidden
    Journal of general internal medicine

    Martin M, Sedighi Manesh R, Henderson MC, Critchfield JM. Diagnostic Scheming. Volume 30 of Issue 12. Journal of general internal medicine 2015. PMID: 26307386


  36. Hidden
    Journal of paediatrics and child health

    Ortega-García JA, Martin M, López-Fernández MT, Fuster-Soler JL, Donat-Colomer J, López-Ibor B, Claudio L, Ferrís-Tortajada J. Transgenerational tobacco smoke exposure and childhood cancer: an observational study. Journal of paediatrics and child health 2010. PMID: 20412413


  37. Hidden
    Journal of medical case reports

    Martin M, Rodriguez K, Sánchez-Sauco M, Zambudio-Carmona G, Ortega-García JA. Household exposure to pesticides and bladder exstrophy in a newborn baby boy: a case report and review of the literature. Journal of medical case reports 2009. PMID: 19830118


  38. Hidden
    European journal of pediatrics

    Ortega-García JA, Rodriguez K, Calatayud M, Martin M, Vélez D, Devesa V, Sánchez-Alarcon MC, Torres Cantero AM, Galindo-Cascales C, Gil-Vázquez JM, Sánchez-Sauco MF, Sánchez-Solís M, Alfonso-Marsilla B, Romero-Braquehais F. Estimated intake levels of methylmercury in children, childbearing age and pregnant women in a Mediterranean region, Murcia, Spain. European journal of pediatrics 2008. PMID: 19096874


  39. Hidden
    Diabetes care

    Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD. Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes care 2008. PMID: 18202246